Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Pregnenolone for PTSD and Depression in Veterans
NCT00993629Phase 2Withdrawn
- Sponsor
- United States Department of Veterans Affairs
- Start
- Jan 2010
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregnenolone in post-traumatic stress disorder (PTSD), major depressive disorder (MDD), sponsored by United States Department of Veterans Affairs. Planned start Jan 2010; status: withdrawn.
02
Drugs
pregnenolone
03
Conditions
post-traumatic stress disorder (PTSD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00993629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993629.